Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
s-ketamine versus placebo for neuropathic pain in cancer patients
ISRCTN49116945Phase 3Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Neuralgia comparing s-ketamine + best standard pain management with placebo + best standard pain management (2 arms). Primary endpoint: Improvement in malignant neuropathic pain. Started Apr 2009; status: completed.
02
Drugs
esketamine
03
Conditions
Neuralgia
Beyond the preview
Go deeper on ISRCTN49116945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN49116945.